JAK Inhibitor Succeeds in Refractory Vasculitis
Patients with treatment-resistant granulomatosis with polyangiitis (GPA) may see improvement…
Browsing Tag
vasculitis
ANCA-Associated Vasculitis: Parsing the Kidney Complications
Bearing in mind that renal impairment is among the worst complications of ANCA-associated…
Scattered Brain Bleeds, Vasculitis in Alzheimer’s Trial Death
A fatal bleeding event in an Alzheimer's clinical trial participant may have been linked…
Ashton Kutcher’s Autoimmune Vasculitis
In a clip from an episode of the Paramount+ docuseries "The Checkup: With Dr. David Agus"…
ANCA-Associated Vasculitis: Novel Biologic Shows Promise for Replacing Steroids
PHILADELPHIA -- An investigational monoclonal antibody targeting C5a complement, when partially or fully substituted for…
Global Vasculitis Treatment Market is Expected to Reach USD 350.1 Million by 2031:…
Portland, OR, Oct. 31, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Vasculitis Treatment Market was estimated at $250.1 million in 2021…
Global Vasculitis Pipeline Insights | Clinical Trials Evaluation Research Report 2022…
Las Vegas, USA, April 07, 2022 (GLOBE NEWSWIRE) -- Global Vasculitis Pipeline Insights | Clinical Trials Evaluation Research Report 2022 by DelveInsight Vasculitis Pipeline constitutes…
Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by…
SAN CARLOS, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for…
Avacopan Helps Vasculitis Patients With Renal Impairment Wean Off Steroids
More patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and renal disease on avacopan (Tavneos) had…
FDA Gives Thumbs Up to ANCA-Associated Vasculitis Drug
The FDA approved the oral complement 5a receptor inhibitor avacopan (Tavneos) for the treatment…